Buscar
-
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
(BMC Infectious Diseases. vol. 20, n° 1, pp. 850, 2020-11-16)Article de revueLibre acceso -
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials
(CPT: Pharmacometrics and Systems Pharmacology, 2020)Article de revueLibre acceso -
Immune evasion means we need a new COVID-19 social contract
(The Lancet Public Health. vol. 6, n° 4, pp. e199-e200, 2021-02)Article de revueLibre acceso -
Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020
(Emerging Infectious Diseases. vol. 26, n° 7, pp. 1562-1566, 2020)Article de revue -
Detection of Zika Virus Replication in Human Semen by Reverse-Transcription Polymerase Chain Reaction Targeting of Antisense Ribonucleic Acid
(Journal of Infectious Diseases. vol. 222, n° 2, pp. 319-323, 2020)Article de revue -
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load
(CPT: Pharmacometrics and Systems Pharmacology. vol. 9, n° 9, pp. 509-514, 2020-09)Article de revueLibre acceso -
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
(PLoS Neglected Tropical Diseases. vol. 14, n° 6, pp. e0008259, 2020)Article de revueLibre acceso -
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
(The Lancet Infectious Diseases, 2020)Article de revue -
Dermatoses in international travellers seen at Bordeaux teaching hospital travel clinic, 2015-2018: a GeoSentinel-based study
(Clinical and Experimental Dermatology. vol. 45, n° 5, pp. 580-583, 2020)Article de revueLibre acceso -
Zika among international travellers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice
(Journal of Travel Medicine. vol. 27, n° 4, 2020)Article de revue